Many people first learned about mRNA vaccines during the coronavirus pandemic, when the companies Pfizer-BioNTech and Moderna released their COVID-19 vaccines. The Pfizer-BioNTech shot was the first ...

The 5’ cap structure exerts profound impacts on mRNA vaccine stability, translational efficiency, and evasion of innate immunity, encompassing key enzymatic components: triphosphatase (TPase), ...

Refeyn, developer of pioneering mass photometry technology, expands its global adoption across contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs).

A new study led by researchers at Washington University School of Medicine in St. Louis has found that an investigational ...

Moderna’s investigational mRNA flu vaccine generated broader, longer-lasting immune responses than a standard flu shot.

Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and how that risk might be reduced. They found that the vaccines can spark a two ...

Delivering mRNA to specific cell types remains challenging. Recent work opens the possibility of using synthetic RNA transfer pathways to engineer mRNA ‘delivery cells’. These cells could home to ...

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the ...